« Beyond Weight Loss: Practical Considerations for use of Glucagon like Peptide-1 (GLP-1) and Incretin Therapy in Inflammatory Skin Disease », Can Dermatol Today, vol. 7, nᵒ 3, p. 11–16, sept. 2026, doi: 10.58931/cdt.2026.73168.